Skip to main content
. Author manuscript; available in PMC: 2021 Aug 4.
Published in final edited form as: J Clin Lipidol. 2019 Oct 31;14(1):53–65.e2. doi: 10.1016/j.jacl.2019.10.013

Table 2.

Characteristics of recruited subjects

Parameters Measures (n=37)
Demographics and medical history
Age (years) 34.8 ± 12.5
Male sex, n (%) 15 (40.5)
Female sex, n (%) 22 (59.5)
Ethnicity, n (%)
 White 19 (51.4)
 Black 7 (18.9)
 Asian 11 (29.7)
Body mass index (kg/m2) 24.3 ± 3.4
Clinical and laboratory values
Systolic BP (mmHg) 118.9 ± 12.6
Diastolic BP (mmHg) 70.6 ± 9
TC (mg/dL) 176 ± 45.7
TG (mg/dL) 83.8 ± 49.1
HDL-C (mg/dL) 62.2 ± 18.4
LDL-C (mg/dL) 97.2 ± 44.6
ApoA-I (mg/dL) 155.1 ± 31.1
ApoB (mg/dL) 88.7 ± 32.4
hsCRP (mg/L) 2.4 (0.5-3.0)
HOMA-IR 1.9 (1.1- 2.4)
Insulin (μU/mL) 8.3 ± 5.2
Glucose (mg/dL) 92.6 ± 8.4
HbA1C (%) 5 ± 0.5
AST (U/L) 21.5 ± 12.5
ALT (U/L) 18.4 ± 9.5
TSH (μlU/mL) 2.1 ± 1.4
Uric Acid (mg/dL) 5.4 ± 1.3
Creatinine (mg/dL) 0.9 ± 0.2
RBC (M/uL) 4.6 ± 0.5
WBC (K/uL) 5.6 ± 1.5

N/A: Not applicable; BP: blood pressure; TC: total cholesterol; TG: triglycerides; HDL-C: HDL cholesterol; LDL-C: LDL cholesterol; hsCRP: high-sensitivity C-reactive protein; HOMA-IR: homeostatic model assessment of insulin resistance; HbA1C: hemoglobin A1c; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TSH: thyroid-stimulating hormone; RBC: red blood cells; WBC: white blood cells. Data represented as mean ± SD (n = 37) or interquartile range (IQR) for parametric and non-parametric variables respectively and as n (%) for categorical variables.

HHS Vulnerability Disclosure